코리아 R&D 패러독스에 관한 실증적 접근
기초연구 2023-01
$9.20
SKU
9788961128919
[Free shipping over $100]
Standard Shipping estimated by Mon 12/9 - Fri 12/13 (주문일로부 10-14 영업일)
Express Shipping estimated by Wed 12/4 - Fri 12/6 (주문일로부 7-9 영업일)
* 안내되는 배송 완료 예상일은 유통사/배송사의 상황에 따라 예고 없이 변동될 수 있습니다.
| Publication Date | 2023/11/30 |
| Pages/Weight/Size | 163*236*23mm |
| ISBN | 9788961128919 |
| Categories | 사회 정치 > 행정 |
Contents
국문 요약 ·····································································································i
영문 요약 ····································································································I
제1장 연구 개요 ·························································································
제1절 연구 배경 및 목적·················································································
제2절 연구 내용 및 수행 전략·········································································3
1. 연구 수행 전략························································································3
2. 연구 내용 구성 및 모듈별 목표·······························································4
제2장 유럽과 한국의 R&D 패러독스 논의 동향 ·······························8
제1절 R&D 패러독스란? ··················································································8
제2절 European Paradox 논의 동향···························································11
1. 경제적 성과···························································································12
2. 과학적 성과···························································································12
3. 분야별 과학적 성과의 차이····································································1\
제3절 Swedish Paradox 논의 동향·····························································14
1. R&D 투자·····························································································15
2. 경제적 성과···························································································15
3. 혁신체제·································································································16
4. 이론적 검토···························································································17
제4절 한국의 R&D 패러독스 논의································································18
제5절 시사점··································································································19
1. 한국 연구를 위한 시사점·······································································19
2. R&D 투자와 경제적 성과 사이의 인과관계 입증 문제··························19
3. 패러독스의 원인 분석············································································20
제3장 R&D 패러독스 진단 지표 검토 ··············································2
제1절 연구개요······························································································22
제2절 지표별 진단 결과·················································································25
1. 투입(Input)과 성과(Output)지표···························································25
제3절 지표별 현행화 결과··············································································39
1. 국가R&D 투자 및 과제·········································································39
2. 논문/특허·······························································································40
3. 기술이전/사업화·····················································································43
제4절 결론과 시사점······················································································49
제4장 R&D 효과 분석 연구 메타 리뷰 ············································52
제1절 개요·····································································································52
1. 메타 리뷰의 개요···················································································52
2. 메타 리뷰의 기준과 방법·······································································53
제2절 R&D 효과 분석 연구의 메타 리뷰······················································55
1. 정부 R&D 투자 관점·············································································55
2. 민간 R&D 투자 관점·············································································63
제3절 결론 및 시사점····················································································74
제5장 R&D 평가 제도 및 지표 리뷰 ················································83
제1절 정부R&D 성과평가 제도······································································83
1. 정부R&D 성과평가················································································83
2. 정부R&D사업 성과평가·········································································85
3. 정부R&D제도 혁신방안·········································································88
제2절 정부R&D사업 성과지표·······································································91
1. 과학적 성과···························································································95
2. 기술적 성과···························································································96
3. 경제적 성과···························································································97
4. 사회적 성과···························································································98
5. 인프라 성과···························································································99
제3절 주요 시사점 ·····················································································101
제6장 R&D 패러독스 진단의 주안점 및 분석 프레임 워크 ········107
제1절 진단 주안점: ? R&D 효율성 관점···················································107
제2절 진단 주안점: ? 기술사업화 효율성 관점··········································113
1. 기술사업화 효율성에 대한 접근···························································113
2. 기술사업화 효율성에 대한 논의···························································120
3. 기술사업화 효율성 접근의 방향 ························································12
제3절 코리아 R&D 패러독스 진단 주안점 및 프레임워크···························125
제7장 STI 지표 글로벌 비교 분석 ···················································128
제1절 분석 개요···························································································128
1. 분석 배경·····························································································128
2. 분석 방법·····························································································131
제2절 R&D 생산성 글로벌 비교(1): 과학기술 성과 지표····························133
1. 논문 수································································································133
2. 피인용 상위 10% 논문 수···································································136
3. PCT 특허 수·······················································································139
제3절 R&D 생산성 글로벌 비교(2): 경제적 성과 지표································142
1. 지식재산 사용료 수입··········································································142
2. 첨단산업 제품 수출액··········································································145
제4절 소결···································································································148
1. 분석 결과 정리····················································································148
2. 시사점··································································································149
제8장 논문 질적수준 글로벌 비교분석 ·············································150
제1절 한국 및 주요 국가의 논문 양적 분석················································150
1. 논문 분석 개요····················································································150
2. 논문 수 기준 분석···············································································152
제2절 한국 및 주요 국가의 논문 질적수준 분석··········································159
1. 과학기술 분야별 논문 평균 피인용······················································159
2. 고인용 상위 논문 분석········································································163
3. R&D 투자 대비 고인용 상위 논문 분석··············································171
제3절 소결···································································································177
제9장 R&D 경제적 효과 글로벌 비교분석 ·····································178
제1절 R&D의 경제적 효과에 대한 주요 연구··············································178
제2절 연구개발 투자의 경제적 효과 실증 분석············································181
1. 자료 수집·····························································································181
2. 모형설정과 추정···················································································183
3. 결과분석 및 국제비교··········································································187
제3절 소결 및 시사점··················································································191
제10장 국가연구개발사업 성과 효율성 분석 ····································193
제1절 분석 개요···························································································193
제2절 코리아 R&D 패러독스 진단 모형 개발··············································194
1. 분석 데이터 구축·················································································194
2. 분석 모형·····························································································196
제3절 국가연구개발사업 효율성 분석 결과: 논문효율성·······························199
1. 연도별 효율성 분석··············································································199
2. 연구단계별 효율성 분석·······································································200
3. 기술분야별 효율성 분석·······································································202
제4절 국가연구개발사업 효율성 분석 결과: 특허효율성·······························203
1. 국내특허 효율성 분석··········································································203
2. 해외특허 효율성 분석··········································································208
제5절 국가연구개발사업 효율성 분석 결과: 기술료효율성····························212
1. 정부연구비 기준 기술료효율성·····························································212
2. 특허출원 기준 기술료효율성································································215
제6절 소결···································································································218
제11장 정부·민간 특허성과 질적 수준 비교분석 ···························221
제1절 분석에 활용된 자료와 분석방향·························································221
1. 분석에 활용된 자료··············································································221
2. 분석 방법·····························································································223
제2절 특허 출원 수·····················································································225
1. 정부·민간 특허 출원 수·······································································225
2. 출원인 유형별 출원 수········································································226
제3절 특허의 기술적 활용···········································································227
1. 특허인용 자료의 의미와 중요성···························································227
2. 출원인 인용·························································································228
3. 심사관 인용·························································································233
제4절 특허의 경제적 활용···········································································238
1. 양도·····································································································238
2. 전용실시······························································································243
3. 통상실시······························································································248
제5절 미활용 특허·······················································································253
1. 미활용 특허의 정의··············································································253
제6절 소결···································································································255
제12장 정부 연구개발투자 파급효과 분석 ·····································256
제1절 서론···································································································256
1. 기업의 R&D 활동과 정부 연구개발투자··············································256
2. 본 연구의 목적 및 범위·······································································257
제2절 선행연구····························································································259
제3절 R&D 수익률 측정 방법론 및 데이터·················································261
1. 방법론··································································································261
2. 데이터··································································································263
3. R&D 스톡···························································································265
제4절 R&D 수익률 분석 결과·····································································269
1. R&D의 탄력성 추정 결과····································································269
2. R&D의 사회적 수익률과 사적 수익률 추정 결과·································27
제5절 정부 연구개발투자의 영향··································································275
1. 정부 연구개발사업 참여 가능성과 R&D의 사회적 파급효과················275
2. R&D의 수익률과 정부 연구개발투자···················································278
제6절 결론 및 시사점··················································································282
제13장 코리아 R&D 패러독스 진단결과 종합 ······························284
제1절 코리아 R&D 패러독스 논의 리뷰 ····················································284
제2절 코리아 R&D 패러독스 진단 주안점 및 분석 프레임워크···················287
제3절 코리아 R&D 패러독스 분석 주요 결과 종합·····································290
제4절 코리아 R&D 패러독스 분석 결론······················································303
참고문헌 ································································································307
부록 1. R&D 효과 분석 연구 메타 리뷰 ·······································327
부록 2. 정부R&D사업 성과 분석 및 평가 결과 ··························344
부록 3. 논문 질적 성과 비교 (분야별) ··········································354
영문 요약 ····································································································I
제1장 연구 개요 ·························································································
제1절 연구 배경 및 목적·················································································
제2절 연구 내용 및 수행 전략·········································································3
1. 연구 수행 전략························································································3
2. 연구 내용 구성 및 모듈별 목표·······························································4
제2장 유럽과 한국의 R&D 패러독스 논의 동향 ·······························8
제1절 R&D 패러독스란? ··················································································8
제2절 European Paradox 논의 동향···························································11
1. 경제적 성과···························································································12
2. 과학적 성과···························································································12
3. 분야별 과학적 성과의 차이····································································1\
제3절 Swedish Paradox 논의 동향·····························································14
1. R&D 투자·····························································································15
2. 경제적 성과···························································································15
3. 혁신체제·································································································16
4. 이론적 검토···························································································17
제4절 한국의 R&D 패러독스 논의································································18
제5절 시사점··································································································19
1. 한국 연구를 위한 시사점·······································································19
2. R&D 투자와 경제적 성과 사이의 인과관계 입증 문제··························19
3. 패러독스의 원인 분석············································································20
제3장 R&D 패러독스 진단 지표 검토 ··············································2
제1절 연구개요······························································································22
제2절 지표별 진단 결과·················································································25
1. 투입(Input)과 성과(Output)지표···························································25
제3절 지표별 현행화 결과··············································································39
1. 국가R&D 투자 및 과제·········································································39
2. 논문/특허·······························································································40
3. 기술이전/사업화·····················································································43
제4절 결론과 시사점······················································································49
제4장 R&D 효과 분석 연구 메타 리뷰 ············································52
제1절 개요·····································································································52
1. 메타 리뷰의 개요···················································································52
2. 메타 리뷰의 기준과 방법·······································································53
제2절 R&D 효과 분석 연구의 메타 리뷰······················································55
1. 정부 R&D 투자 관점·············································································55
2. 민간 R&D 투자 관점·············································································63
제3절 결론 및 시사점····················································································74
제5장 R&D 평가 제도 및 지표 리뷰 ················································83
제1절 정부R&D 성과평가 제도······································································83
1. 정부R&D 성과평가················································································83
2. 정부R&D사업 성과평가·········································································85
3. 정부R&D제도 혁신방안·········································································88
제2절 정부R&D사업 성과지표·······································································91
1. 과학적 성과···························································································95
2. 기술적 성과···························································································96
3. 경제적 성과···························································································97
4. 사회적 성과···························································································98
5. 인프라 성과···························································································99
제3절 주요 시사점 ·····················································································101
제6장 R&D 패러독스 진단의 주안점 및 분석 프레임 워크 ········107
제1절 진단 주안점: ? R&D 효율성 관점···················································107
제2절 진단 주안점: ? 기술사업화 효율성 관점··········································113
1. 기술사업화 효율성에 대한 접근···························································113
2. 기술사업화 효율성에 대한 논의···························································120
3. 기술사업화 효율성 접근의 방향 ························································12
제3절 코리아 R&D 패러독스 진단 주안점 및 프레임워크···························125
제7장 STI 지표 글로벌 비교 분석 ···················································128
제1절 분석 개요···························································································128
1. 분석 배경·····························································································128
2. 분석 방법·····························································································131
제2절 R&D 생산성 글로벌 비교(1): 과학기술 성과 지표····························133
1. 논문 수································································································133
2. 피인용 상위 10% 논문 수···································································136
3. PCT 특허 수·······················································································139
제3절 R&D 생산성 글로벌 비교(2): 경제적 성과 지표································142
1. 지식재산 사용료 수입··········································································142
2. 첨단산업 제품 수출액··········································································145
제4절 소결···································································································148
1. 분석 결과 정리····················································································148
2. 시사점··································································································149
제8장 논문 질적수준 글로벌 비교분석 ·············································150
제1절 한국 및 주요 국가의 논문 양적 분석················································150
1. 논문 분석 개요····················································································150
2. 논문 수 기준 분석···············································································152
제2절 한국 및 주요 국가의 논문 질적수준 분석··········································159
1. 과학기술 분야별 논문 평균 피인용······················································159
2. 고인용 상위 논문 분석········································································163
3. R&D 투자 대비 고인용 상위 논문 분석··············································171
제3절 소결···································································································177
제9장 R&D 경제적 효과 글로벌 비교분석 ·····································178
제1절 R&D의 경제적 효과에 대한 주요 연구··············································178
제2절 연구개발 투자의 경제적 효과 실증 분석············································181
1. 자료 수집·····························································································181
2. 모형설정과 추정···················································································183
3. 결과분석 및 국제비교··········································································187
제3절 소결 및 시사점··················································································191
제10장 국가연구개발사업 성과 효율성 분석 ····································193
제1절 분석 개요···························································································193
제2절 코리아 R&D 패러독스 진단 모형 개발··············································194
1. 분석 데이터 구축·················································································194
2. 분석 모형·····························································································196
제3절 국가연구개발사업 효율성 분석 결과: 논문효율성·······························199
1. 연도별 효율성 분석··············································································199
2. 연구단계별 효율성 분석·······································································200
3. 기술분야별 효율성 분석·······································································202
제4절 국가연구개발사업 효율성 분석 결과: 특허효율성·······························203
1. 국내특허 효율성 분석··········································································203
2. 해외특허 효율성 분석··········································································208
제5절 국가연구개발사업 효율성 분석 결과: 기술료효율성····························212
1. 정부연구비 기준 기술료효율성·····························································212
2. 특허출원 기준 기술료효율성································································215
제6절 소결···································································································218
제11장 정부·민간 특허성과 질적 수준 비교분석 ···························221
제1절 분석에 활용된 자료와 분석방향·························································221
1. 분석에 활용된 자료··············································································221
2. 분석 방법·····························································································223
제2절 특허 출원 수·····················································································225
1. 정부·민간 특허 출원 수·······································································225
2. 출원인 유형별 출원 수········································································226
제3절 특허의 기술적 활용···········································································227
1. 특허인용 자료의 의미와 중요성···························································227
2. 출원인 인용·························································································228
3. 심사관 인용·························································································233
제4절 특허의 경제적 활용···········································································238
1. 양도·····································································································238
2. 전용실시······························································································243
3. 통상실시······························································································248
제5절 미활용 특허·······················································································253
1. 미활용 특허의 정의··············································································253
제6절 소결···································································································255
제12장 정부 연구개발투자 파급효과 분석 ·····································256
제1절 서론···································································································256
1. 기업의 R&D 활동과 정부 연구개발투자··············································256
2. 본 연구의 목적 및 범위·······································································257
제2절 선행연구····························································································259
제3절 R&D 수익률 측정 방법론 및 데이터·················································261
1. 방법론··································································································261
2. 데이터··································································································263
3. R&D 스톡···························································································265
제4절 R&D 수익률 분석 결과·····································································269
1. R&D의 탄력성 추정 결과····································································269
2. R&D의 사회적 수익률과 사적 수익률 추정 결과·································27
제5절 정부 연구개발투자의 영향··································································275
1. 정부 연구개발사업 참여 가능성과 R&D의 사회적 파급효과················275
2. R&D의 수익률과 정부 연구개발투자···················································278
제6절 결론 및 시사점··················································································282
제13장 코리아 R&D 패러독스 진단결과 종합 ······························284
제1절 코리아 R&D 패러독스 논의 리뷰 ····················································284
제2절 코리아 R&D 패러독스 진단 주안점 및 분석 프레임워크···················287
제3절 코리아 R&D 패러독스 분석 주요 결과 종합·····································290
제4절 코리아 R&D 패러독스 분석 결론······················································303
참고문헌 ································································································307
부록 1. R&D 효과 분석 연구 메타 리뷰 ·······································327
부록 2. 정부R&D사업 성과 분석 및 평가 결과 ··························344
부록 3. 논문 질적 성과 비교 (분야별) ··········································354